Cargando…

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

C-erbB-2 prognostic value for survival in patients with lung cancer remains controversial. We performed a systematic review of the literature to clarify its impact. Studies were identified by an electronic search in order to aggregate the survival results, after a methodological assessment using the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meert, A-P, Martin, B, Paesmans, M, Berghmans, T, Mascaux, C, Verdebout, J-M, Delmotte, P, Lafitte, J-J, Sculier, J-P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376951/ https://www.ncbi.nlm.nih.gov/pubmed/12966408 http://dx.doi.org/10.1038/sj.bjc.6601252

Ejemplares similares

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
por: Meert, A-P, et al.
Publicado: (2002)

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
por: Martin, B, et al.
Publicado: (2003)

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis
por: Martin, B, et al.
Publicado: (2004)

Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
por: Meert, Anne-Pascale, et al.
Publicado: (2001)

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
por: Mascaux, C, et al.
Publicado: (2006)

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
por: Mascaux, C, et al.
Publicado: (2005)

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature
por: Sculier, J P, et al.
Publicado: (2001)

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
por: Berghmans, Thierry, et al.
Publicado: (2017)

Invasive mechanical ventilation in cancer patients: prior non-invasive ventilation is a poor prognostic factor
por: Meert, A, et al.
Publicado: (2010)

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
por: Berghmans, T, et al.
Publicado: (2007)

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study
por: Berghmans, Thierry, et al.
Publicado: (2015)

Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party
por: Berghmans, Thierry, et al.
Publicado: (2015)

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU
por: Destrebecq, Virginie, et al.
Publicado: (2016)

Advances in target therapy in lung cancer
por: Sculier, Jean-Paul, et al.
Publicado: (2015)

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
por: Sculier, J-P, et al.
Publicado: (2000)

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
por: Sculier, J P, et al.
Publicado: (2001)

Updates in oncology
por: Sculier, Jean-Paul, et al.
Publicado: (2014)

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment
por: Fischler, Rebecca, et al.
Publicado: (2016)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

HER-2/neu diagnostics in breast cancer
por: Carney, Walter P, et al.
Publicado: (2007)

Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours.
por: DiGiovanna, M. P., et al.
Publicado: (1996)

HER2/neu testing in primary colorectal carcinoma
por: Ingold Heppner, B, et al.
Publicado: (2014)

Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005)

HER-2/neu Testing and Therapy in Gastroesophageal Adenocarcinoma
por: Moelans, Cathy B., et al.
Publicado: (2010)

Review of the Role of HER2/neu in Colorectal Carcinomas
por: Achalla, Lakshmi Sai Vijay, et al.
Publicado: (2022)

HER-2/neu oncogene: what does amplification mean?
por: Pavy, J. J., et al.
Publicado: (1993)

Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8(+) T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice
por: Chen, Y, et al.
Publicado: (2011)

Systematic assessment of HER2/neu in gynecologic neoplasms, an institutional experience
por: Woo, Jennifer S., et al.
Publicado: (2016)

Vaccination against Her-2/neu, with focus on peptide-based vaccines
por: Tobias, J., et al.
Publicado: (2022)

The Clinical Importance of the Heterogeneity of HER2 neu
por: Davila, Enrique, et al.
Publicado: (2010)

The Prognostic Significance of Her2-Neu Over expression in Gastric Carcinomas
por: Ansari, J, et al.
Publicado: (2011)

Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab
por: Todeschini, P, et al.
Publicado: (2011)

The expression of HER2/neu in patients with lung cancer and its associated factors
por: Lashkarizadeh, Mohammadreza, et al.
Publicado: (2023)

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas
por: Hirsch, F R, et al.
Publicado: (2002)

Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
por: Bahl, A., et al.
Publicado: (2018)

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
por: Warneke, V. S., et al.
Publicado: (2013)

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
por: Brodowicz, T, et al.
Publicado: (2001)

HER-2/neu and E-cadherin Expression and Microsatellite Instability in Gastric Dysplasia
por: Ahmadi, L, et al.
Publicado: (2011)

HER 2/neu protein expression in colorectal cancer
por: Schuell, B, et al.
Publicado: (2006)

Anti-HER2/Neu passive-aggressive immunotherapy
por: Mortenson, Eric D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i9p42bpo8grq3e6oj89atlqci1